InfuSystem Holdings Files 8-K for Regulation FD Disclosure
Ticker: INFU · Form: 8-K · Filed: Oct 31, 2024 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Oct 31, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, Regulation FD, Disclosure
TL;DR
InfuSystem Holdings dropped an 8-K for a Reg FD disclosure on 10/31 - details TBD.
AI Summary
InfuSystem Holdings, Inc. filed an 8-K on October 31, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it indicates a material event requiring immediate public notification. The company, formerly known as HAPC, Inc. and Healthcare Acquisition Partners Corp., is incorporated in Delaware and headquartered in Rochester Hills, Michigan.
Why It Matters
This 8-K filing signals a potentially significant event or piece of information that InfuSystem Holdings is required to disclose to the public under Regulation FD, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: medium — An 8-K filing for a Regulation FD disclosure often indicates material information is being released, which can introduce uncertainty and potential volatility until the specifics are understood.
Key Numbers
- 001-35020 — SEC File Number (Identifies the company's filing with the SEC.)
- 20-3341405 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- HAPC, Inc. (company) — Former company name
- Healthcare Acquisition Partners Corp. (company) — Former company name
- October 31, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Rochester Hills, Michigan (location) — Principal executive offices
FAQ
What specific information is being disclosed under Regulation FD?
The provided text of the 8-K filing does not specify the details of the Regulation FD disclosure, only that it is being filed.
When was this 8-K filing submitted?
The filing was submitted as of October 31, 2024.
What is InfuSystem Holdings, Inc.'s principal executive office address?
The principal executive offices are located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.
What were InfuSystem Holdings, Inc.'s former company names?
The company was formerly known as HAPC, Inc. and Healthcare Acquisition Partners Corp.
What is the SIC code for InfuSystem Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-10-31 06:31:04
Filing Documents
- infu-20241031.htm (8-K) — 28KB
- exhibit991announcementofea.htm (EX-99.1) — 8KB
- infusystem_safesmarttruste.jpg (GRAPHIC) — 760KB
- 0001628280-24-044401.txt ( ) — 1197KB
- infu-20241031.xsd (EX-101.SCH) — 2KB
- infu-20241031_lab.xml (EX-101.LAB) — 21KB
- infu-20241031_pre.xml (EX-101.PRE) — 12KB
- infu-20241031_htm.xml (XML) — 3KB
01 - Regulation FD
Item 7.01 - Regulation FD On October 31, 2024 , InfuSystem Holdings, Inc. (the "Company") issued a press release announcing that the Company will disclose its financial results for the third quarter 2024 on Thursday, November 7, 2024 before the market opens. The Company will also conduct a conference call for all interested investors on Thursday, November 7, 2024 at 9:00 a.m. Eastern Time. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated October 31 , 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Richard DiIorio Richard DiIorio Chief Executive Officer and Director Dated: October 31, 2024